University of Oslo School of Pharmacy

Implementation of Pharmacogenetic Testing in Hospital Wards

Role: collaborator

Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity

Role: lead

Generic Tacrolimus in the Elderly - Prograf® vs Tacni®

Role: lead

Insulin Secretion and Advagraf

Role: lead

Interaction Between Rimonabant and Cyclosporine and Tacrolimus

Role: lead

Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Role: lead

Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin

Role: lead

Computer Guided Doing of Tacrolimus in Renal Transplantation

Role: lead

Acetazolamide for Respiratory Failure in Combination With Metabolic Alkalosis

Role: lead

Effects of Cyclosporine A on Pancreatic Insulin Secretion

Role: lead

The Rosuvastatin In TrAnsplant Recipients Study

Role: lead

Sitagliptin in Renal Transplant Recipients

Role: lead

Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant

Role: lead

Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

Role: collaborator

Metabolic Pattern of Cyclosporine A and Acute Renal Failure

Role: lead

Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy

Role: lead

Intracellular and Renal/Myocardial Tissue Concentrations of Cyclosporine A (CsA) and Rejection Frequency Following Transplantation

Role: lead

Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery

Role: lead

Efficacy and Safety of Nateglinide Treatment in Renal Transplant Recipients

Role: lead

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk

Role: lead